PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.96%
Revenue growth at 50-75% of 3391.T's 9.43%. Martin Whitman would worry about competitiveness or product relevance.
8.17%
Gross profit growth 1.25-1.5x 3391.T's 6.43%. Bruce Berkowitz would see if strategic sourcing or brand premium explains outperformance.
24.49%
EBIT growth 50-75% of 3391.T's 45.99%. Martin Whitman would suspect suboptimal resource allocation.
28.69%
Operating income growth at 75-90% of 3391.T's 32.19%. Bill Ackman would demand a plan to enhance operating leverage.
-17.71%
Negative net income growth while 3391.T stands at 51.55%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-17.71%
Negative EPS growth while 3391.T is at 61.92%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-17.71%
Negative diluted EPS growth while 3391.T is at 61.82%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.00%
Share reduction more than 1.5x 3391.T's 0.07%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.00%
Diluted share reduction more than 1.5x 3391.T's 0.07%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
34.57%
10Y CAGR of 34.57% while 3391.T is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
-15.64%
Negative 5Y CAGR while 3391.T stands at 73.62%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
32.43%
3Y revenue/share CAGR at 75-90% of 3391.T's 41.11%. Bill Ackman would expect new product strategies to close the gap.
-100.00%
Negative 10Y OCF/share CAGR while 3391.T stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
71.27%
10Y net income/share CAGR of 71.27% while 3391.T is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
-21.87%
Negative 5Y net income/share CAGR while 3391.T is 72.48%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
70.89%
3Y net income/share CAGR 1.25-1.5x 3391.T's 59.64%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
No Data
No Data available this quarter, please select a different quarter.
24.39%
Below 50% of 3391.T's 83.17%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
70.99%
3Y equity/share CAGR above 1.5x 3391.T's 42.51%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
-100.00%
Cut dividends over 10 years while 3391.T stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
4.55%
Our AR growth while 3391.T is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
0.14%
We show growth while 3391.T is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
2.08%
Positive asset growth while 3391.T is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
4.03%
Positive BV/share change while 3391.T is negative. John Neff sees a clear edge over a competitor losing equity.
-30.60%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
94.28%
SG&A growth well above 3391.T's 1.39%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.